Clinical features and radiological manifestations of COVID-19 disease

Coronavirus disease 2019 (COVID-19) was discovered after unusual cases of severe pneumonia emerged in December 2019 in Wuhan Province (China). Coronavirus is a family of single-stranded RNA viruses. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted from person to person. Al...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of radiology Vol. 12; no. 11; pp. 247 - 260
Main Authors Landete, Pedro, Quezada Loaiza, Carlos Andrés, Aldave-Orzaiz, Beatriz, Muñiz, Susana Hernández, Maldonado, Antonio, Zamora, Enrique, Sam Cerna, Allan Charles, Del Cerro, Elia, Alonso, Raquel Cano, Couñago, Felipe
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 28.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Coronavirus disease 2019 (COVID-19) was discovered after unusual cases of severe pneumonia emerged in December 2019 in Wuhan Province (China). Coronavirus is a family of single-stranded RNA viruses. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted from person to person. Although asymptomatic individuals can transmit the virus, symptomatic patients are more contagious. The incubation period ranges from 3-7 d and symptoms are mainly respiratory, including pneumonia or pulmonary embolism in severe cases. Elevated serum levels of interleukins (IL)-2, IL-6, IL-7 indicate the presence of cytokine release syndrome, which is associated with disease severity. The disease has three main phases: Viral infection, pulmonary involvement, and hyperinflammation. To date, no treatment has proved to be safe or effective. Chest X-ray and computed tomography (CT) are the primary imaging tests for diagnosis of SARS-CoV-2 pneumonia, follow-up, and detection of complications. The main radiological findings are ground-glass opacification and areas of consolidation. The long-term clinical course is unknown, although some patients may develop pulmonary fibrosis. Positron emission tomography-computed tomography (PET-CT) is useful to assess pulmonary involvement, to define the affected areas, and to assess treatment response. The pathophysiology and clinical course of COVID-19 infection remain poorly understood. However, patterns detected on CT and PET-CT may help to diagnose and guide treatment. In this mini review, we analyze the clinical manifestations and radiological findings of COVID-19 infection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Author contributions: Landete P, Quezada Loaiza CA, Aldave-Orzaiz B, Muñiz SH, Maldonado A, Zamora E, Sam-Cerna AC, del Cerro E, Alonso RC, Couñago F analyzed the data and wrote the manuscript; all authors have read and approve the final manuscript.
Corresponding author: Pedro Landete, MD, PhD, Attending Doctor, Department of Pulmonology, H. U. La Princesa, Diego de León 62, Madrid 28006, Spain. landete.pedro@gmail.com
ISSN:1949-8470
1949-8470
DOI:10.4329/wjr.v12.i11.247